Canada announced Wednesday it has signed two agreements with American pharmaceutical firms Pfizer and Moderna for the delivery of COVID-19 vaccines in 2021. Millions of doses will be supplied, but the...

The EU announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine. The European Commission, the bloc’s executive...

A vaccine additive known as an adjuvant can enhance responses to a vaccine containing the exotic avian flu virus H5N1, so that both rookie and veteran elements of the immune response are strengthened,...

Hundreds of COVID-19 vaccine candidates are currently being developed. The way emerging vaccines will be distributed to those who need them is not yet clear. The United States has now twice indicated...

US President Donald Trump recently started using hydroxychloroquine as a preventative cure to coronavirus. However, amid growing safety concerns, a clinical trial on the drug by the World Health Organisation...

A coronavirus vaccine candidate will be tested in a clinical trial in the United Kingdom  starting this week. The vaccine combines a weakened version of a common cold virus with genes coding for the coronavirus’...

Infectious disease scientists report early development of a potential universal vaccine for Ebola viruses that preclinical tests show might neutralize all four species of these deadly viruses infecting...

The race for a COVID-19 vaccine is on, and as the disease continues to upend societies around the world, public health officials are calling upon pharmaceutical companies to share their intellectual property—a...

Three potential COVID-19 vaccines are making fast progress in early-stage testing in volunteers in China and the U.S., but it’s still a long road to prove if they’ll really work. China’s...

Pharma giants Sanofi and GlaxoSmithKline will join forces to work on a coronavirus vaccine they hope will enter clinical trials this year, potentially making it available in the second half of 2021, the...